ConvaTec (CTEC) Gets a Buy from Barclays
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 21 2024
0mins
Source: Business Insider
Analyst Ratings: Barclays analyst Hassan Al-Wakeel has maintained a Buy rating on ConvaTec (CTEC), with an analyst consensus of Strong Buy and a price target of p292.44, indicating a potential upside of 24.65% from current levels.
Company Overview: ConvaTec specializes in advanced wound care, ostomy, continence care, and infusion sets, with its largest revenue contributions coming from advanced wound care and ostomy divisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
